AU2017900495A0 - Formulations of Cannabinoids for the Treatment of Dermatitis and Inflammatory Skin Diseases - Google Patents
Formulations of Cannabinoids for the Treatment of Dermatitis and Inflammatory Skin DiseasesInfo
- Publication number
- AU2017900495A0 AU2017900495A0 AU2017900495A AU2017900495A AU2017900495A0 AU 2017900495 A0 AU2017900495 A0 AU 2017900495A0 AU 2017900495 A AU2017900495 A AU 2017900495A AU 2017900495 A AU2017900495 A AU 2017900495A AU 2017900495 A0 AU2017900495 A0 AU 2017900495A0
- Authority
- AU
- Australia
- Prior art keywords
- cannabinoids
- dermatitis
- formulations
- treatment
- skin diseases
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 208000006641 Skin Disease Diseases 0.000 title 1
- 229930003827 cannabinoid Natural products 0.000 title 1
- 239000003557 cannabinoid Substances 0.000 title 1
- 230000002149 cannabinoid Effects 0.000 title 1
- 229940065144 cannabinoids Drugs 0.000 title 1
- 201000004624 dermatitis Diseases 0.000 title 1
- 231100000406 dermatitis Toxicity 0.000 title 1
- 230000002757 inflammatory Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Priority Applications (10)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP18754514.0A EP3582768A4 (en) | 2017-02-15 | 2018-01-24 | Formulations of cannabinoids for the treatment of dermatitis and inflammatory skin diseases |
| CA3053500A CA3053500A1 (en) | 2017-02-15 | 2018-01-24 | Formulations of cannabinoids for the treatment of dermatitis and inflammatory skin diseases |
| CN201880023264.5A CN110545807B (en) | 2017-02-15 | 2018-01-24 | Cannabinoid formulations for the treatment of dermatitis and inflammatory skin disorders |
| IL268720A IL268720B2 (en) | 2017-02-15 | 2018-01-24 | Formulations of cannabinoids for the treatment of dermatitis and inflammatory skin diseases |
| US16/486,290 US20210401768A1 (en) | 2017-02-15 | 2018-01-24 | Formulations of cannabinoids for the treatment of dermatitis and inflammatory skin diseases |
| AU2018221880A AU2018221880B2 (en) | 2017-02-15 | 2018-01-24 | Formulations of cannabinoids for the treatment of dermatitis and inflammatory skin diseases |
| JP2019544865A JP7012089B2 (en) | 2017-02-15 | 2018-01-24 | Preparation of cannabinoids for the treatment of dermatitis and inflammatory bowel disease |
| PCT/AU2018/050044 WO2018148785A1 (en) | 2017-02-15 | 2018-01-24 | Formulations of cannabinoids for the treatment of dermatitis and inflammatory skin diseases |
| BR112019017018A BR112019017018A2 (en) | 2017-02-15 | 2018-01-24 | cannabinoid formulations for the treatment of dermatitis and inflammatory skin diseases |
| JP2022005183A JP2022050641A (en) | 2017-02-15 | 2022-01-17 | Formulations of cannabinoids for treatment of dermatitis and inflammatory skin diseases |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2017900495A0 true AU2017900495A0 (en) | 2017-03-02 |
Family
ID=
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3582768A4 (en) | Formulations of cannabinoids for the treatment of dermatitis and inflammatory skin diseases | |
| EP3454858A4 (en) | Combination treatment of ocular inflammatory disorders and diseases | |
| EP3448398A4 (en) | Compositions and methods for treatment of skin disorders | |
| PT3377637T (en) | Compositions and methods for the treatment of wounds, disorders, and diseases of the skin | |
| GB201517215D0 (en) | Use of cannabinoids in the treatment of inflammatory skin diseases | |
| EP3538119A4 (en) | Compositions and methods for treating skin diseases and maintaining healthy skin | |
| EP3639833A4 (en) | Agent for the prevention or treatment of fat-related diseases and/or inflammation | |
| EP3268007A4 (en) | Compositions and therapeutic methods for the treatment of complement-associated diseases | |
| EP3503903A4 (en) | Ascaroside treatment of autoimmune and inflammatory diseases | |
| EP3713583A4 (en) | Methods and compositions for treatment of skin | |
| EP3169321A4 (en) | Propolis and extracts thereof for the treatment of skin cancers and improvement of skin health | |
| EP3481958A4 (en) | Methods and compositions for treatment of disorders and diseases involving rdh12 | |
| EP3302464A4 (en) | Use of cannabinoids in the treatment of ocular inflammation and/or pain | |
| EP3119387A4 (en) | Compositions for the treatment of dermatological diseases and disorders | |
| EP3582770A4 (en) | Formulations of cannabinoids for the treatment of acne | |
| EP3538083A4 (en) | Formulations for the treatment of ocular surface diseases and related methods | |
| EP3766503A4 (en) | Application of microrna-210 inhibitor in the preparation of drugs for treating inflammatory skin diseases | |
| PL3515409T3 (en) | Complex and compositions for the treatment of ophthalmic and dermatological diseases | |
| EP3536382A4 (en) | Prophylactic or therapeutic agent for inflammatory skin disease | |
| EP3568138A4 (en) | Compositions and methods for the treatment of myelin related and inflammation related diseases or disorders | |
| EP3581204A4 (en) | Preventive and/or therapeutic agent for infectious diseases or inflammatory diseases | |
| EP3402511A4 (en) | Compositions and methods for treatment of ocular diseases | |
| EP3411479A4 (en) | Treatment and diagnosis of inflammatory disorders | |
| EP3362085A4 (en) | Compositions and methods for the treatment of diseases involving mucin | |
| EP3793522A4 (en) | Compositions and methods for the treatment of inflammatory skin diseases and cancer |